# Design Therapeutics, Inc.: Form SC 13D, filed Mar 31, 2022

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: SC 13D
- Filed: 2022-03-31
- Accepted by EDGAR: Mar 31, 2022, 16:23 ET
- Period: not reported
- Accession: 0000935836-22-000298
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000093583622000298/dsgn13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000093583622000298/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000093583622000298/dsgn13d.htm

Filed Mar 31, 2022.
Source: SEC EDGAR, the filing index for accession 0000935836-22-000298. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
